Search

everythinglearnresearchcommunity

for

Search:↓

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Genetic analysis is crucial for diagnosing ectodermal dysplasia syndromes, and new therapies may help improve skin issues.

Keratin mutations cause skin diseases and could lead to new treatments.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Targeting LPA could help treat skin disorders.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

MVP treatment is effective and safe for recurrent breast cancer.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Genetic variants in PDE6H and LPAR6 cause vision impairment and hair loss in two Pakistani brothers.

A unique hair tumor with a rippled pattern was identified, showing incomplete differentiation and unusual cell arrangements.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.